Reference
All 125 peptides
Every profile uses the same structure: summary, benefits and side effects, vials and reconstitution, a phase-by-phase dosing table, lifestyle notes, identification and linked research.
2 results
PNC-27
PNC-27 is a groundbreaking anti-cancer peptide that selectively kills cancer cells by binding to HDM-2 protein on cancer cell membranes, then forming transmembrane pores that trigger immediate necrotic cell death through osmotic lysis—without requiring p53 tumor suppressor genes, allowing it to work against p53-null cancers resistant to conventional therapy. Laboratory studies show nearly 100% cancer cell elimination in leukemia and breast cancer lines while leaving normal cells completely unharmed due to HDM-2 expression exclusively on cancer cell membranes.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks
Vesilute
Vesilut · Glu-Asp
Research Goal: Evaluating the restoration of bladder wall muscle tone and epithelial tissue regeneration via peptide bioregulators.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; typically repeated every 3–6 months